Description: Taj Pharmaceuticals the well-known Deferoxamine Mesylate for Injection manufacturer in India gives the assurance of high-quality and purity. Deferoxamine is a medicine used in the treatment of chronic iron overload caused due to frequent blood transfusion. It helps in removing the excess iron from the body and reduces the risk of it causing organ damage. Deferoxamine Injection Suppliers ✓ Finished Deferoxamine Mesylate Injection Manufacturers in India – Africa ✓ Middle East ✓ LTAM ✓premium Suppliers & Exporter for Deferoxamine Mesylate for Injection. Taj Pharmaceuticals is a leading manufacturer, exporter, and supplier of Deferoxamine Mesylate for Injection based in Vapi, Gujarat, India. Known for its high-quality and pure formulations, the company provides Deferoxamine Mesylate Injection 500mg for the treatment of chronic iron overload, commonly caused by frequent blood transfusions in conditions like thalassemia and sickle cell anemia. The injection effectively removes excess iron from the body, reducing the risk of organ damage to the liver, heart, and pancreas. Our state-of-the-art manufacturing facilities adhere to GMP and WHO standards, ensuring each batch is safe, potent, and reliable. Taj Pharmaceuticals supplies its products globally, including Africa, the Middle East, and LATAM, catering to hospitals, distributors, and PCD pharma partners. The injection is administered by healthcare professionals, and patients are advised to consult doctors regarding alcohol consumption and potential side effects such as dizziness or vision impairment. With a strong commitment to quality, regulatory compliance, and timely delivery, Taj Pharmaceuticals remains the preferred choice for Deferoxamine Mesylate Injection in India and worldwide. Our comprehensive support, competitive pricing, and trusted reputation make us a reliable partner for healthcare providers and distributors. Taj Pharmaceuticals Ltd is Best Known Manufacturer, Exporter and Supplier Deferoxamine Mesylate for Injection from Vapi, Gujarat India. Deferoxamine Mesylate for Injection 500mg may cause side effects which could affect your ability to drive. If you experience dizziness or other central nervous disturbances, or impairment of vision with the use of Deferoxamine Mesylate for Injection 500mg then you should refrain from driving a vehicle.
Dimensions: 2560 x 1707
File Type: jpeg
File Size: 274 KB
